A practical reference on MC4R agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-27 and is reviewed periodically as new material appears.
Bremelanotide is a moderately large peptide with a molecular mass near 1025 daltons. In lyophilised form it appears as a white to off-white powder and is freely soluble in water and other polar solvents. The intact lactam ring is essential for receptor affinity, while linearised fragments bind far more weakly. Solutions are sensitive to extremes of pH and to prolonged exposure to light and heat, so handling typically involves buffered conditions and cold storage. Its short plasma half-life reflects rapid distribution and clearance rather than chemical breakdown inside the vial.
Development of the peptide passed through several delivery formats, including an intranasal version tested in early trials and an injectable version that entered later clinical study. Regulatory approval for a subcutaneous product in the United States was granted in 2019 after review of controlled trials in premenopausal women. Outside the clinic, the compound circulates in research and non-pharmaceutical markets under its code name, where identity and purity vary considerably between suppliers. Synonyms appearing across technical literature include bremelanotide, PT-141, and Palatin 141.
PT-141 is the research designation for bremelanotide, a synthetic cyclic heptapeptide developed as a melanocortin receptor agonist. The peptide contains seven amino acids with an internal lactam bridge that constrains the backbone into a stable ring. Cyclisation of this kind improves resistance to enzymatic degradation relative to linear analogues. The compound was first explored for effects on melanin production, because several melanocortin receptors influence pigmentation. Its later association with sexual desire emerged from observations made during that early work, and the molecule became the subject of a separate development programme.
Clinical research typically uses randomised, double-blind, placebo-controlled designs. The most common primary endpoint is the desire domain score of the Female Sexual Function Index, sometimes paired with a distress measure. Secondary outcomes include arousal, satisfaction, and event-based counts of satisfying sexual episodes. Across trials, average improvements are modest and individual responses vary widely. Whether benefits persist beyond a few months, and whether they depend on baseline hormone status, remain open questions rather than settled findings.
Melanocortin receptors form a family of five G-protein-coupled receptors designated MC1 through MC5. Bremelanotide binds most strongly at MC4R and MC1R, with weaker activity reported at MC3R and MC5R. MC4R is expressed in hypothalamic nuclei that coordinate energy balance and aspects of sexual behaviour. The prevailing interpretation is that central MC4R activation, rather than peripheral vascular effects alone, drives the reported changes in desire. This account remains partly inferential, since direct receptor-level measurement in living humans is not practical.
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Cyclic heptapeptide | Synthetic melanocortin analogue |
| Molecular formula | C50H68N14O10 | Corresponds to a mass near 1025 daltons |
| Appearance | White to off-white powder | Lyophilised solid before reconstitution |
| Solubility | Soluble in water and polar solvents | Poor solubility in nonpolar media |
| Common synonyms | Bremelanotide, PT-141 | Code name and international name used interchangeably |
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
Development began with intranasal formulations investigated for erectile dysfunction, but blood pressure elevation limited that route and prompted a switch to subcutaneous delivery. Clinical testing then shifted toward hypoactive sexual desire disorder in premenopausal women, and a subcutaneous product received United States approval in 2019. Later trials examined other populations with mixed results, and questions about effect size, durability and patient selection remain open in the peer-reviewed literature. Research interest continues in parallel with the broader melanocortin field, where several synthetic analogues are studied together.
Handling procedures emphasize minimizing moisture uptake, since the dried solid is hygroscopic and can draw water when warmed to room temperature before a vial is opened. Laboratories record lot number, purity, counter-ion content, and residual solvent data supplied by the producer. Impurity profiles are compared run to run, and any shift in retention time or peak shape prompts re-verification against a reference standard. Certificates of analysis are treated as claims to be checked rather than accepted at face value.
Identity and purity testing for this peptide typically relies on reversed-phase high-performance liquid chromatography with ultraviolet detection, reported as area-percent purity. Mass spectrometry, usually in tandem mode, confirms molecular mass and supports quantification in biological matrices. Sequence confirmation may use peptide mapping after enzymatic digestion, while nuclear magnetic resonance and circular dichroism supply supplementary structural detail. No single technique establishes identity alone, so laboratories compare retention time, mass, and fragment pattern against a verified reference standard.
Across literature and commercial listings, the substance appears under several names, including bremelanotide, PT-141, and various brand designations. A CAS registry number provides a unique identifier for the compound, aiding retrieval from chemical databases. Synonym lists may also contain early development codes and descriptive chemical names. When consulting sources, researchers need to confirm that the cited names refer to the same molecular structure to avoid confusion. Naming consistency matters especially when comparing analytical data across publications.
PT-141 is a synthetic cyclic heptapeptide whose development code is bremelanotide. It belongs to the class of melanocortin receptor agonists and acts by mimicking endogenous peptide hormones. The compound originated from research on melanotan II, where investigators exploring derivatives found distinct pharmacological features. Unlike the parent compound, PT-141 showed effects on pathways related to sexual desire and function in early studies, prompting its development as a separate candidate. Its molecular design aimed to separate receptor activity from pigmentary effects.
At the time of the Miller–Urey experiment, Harold Urey was a Professor of Chemistry at the University of Chicago who had a well-renowned career, including receiving the Nobel Prize in Chemistry in 1934 for his isolation of deuterium and leading efforts to use gaseous diffusion for uranium isotope enrichment in support of the Manhattan Project. In 1952, Urey postulated that the high temperatures and energies associated with large impacts in Earth's early history would have provided an atmosphere of methane (CH4), water (H2O), ammonia (NH3), and hydrogen (H2), creating the reducing environment necessary for the Oparin-Haldane "primordial soup" scenario. Stanley Miller arrived at the University of Chicago in 1951 to pursue a PhD under nuclear physicist Edward Teller, another prominent figure in the Manhattan Project. Miller began to work on how different chemical elements were formed in the early universe, but, after a year of minimal progress, Teller was to leave for California to establish Lawrence Livermore National Laboratory and further nuclear weapons research. Miller, having seen Urey lecture on his 1952 paper, approached him about the possibility of a prebiotic synthesis experiment. While Urey initially discouraged Miller, he agreed to allow Miller to try for a year. By February 1953, Miller had mailed a manuscript as sole author reporting the results of his experiment to Science.
=== 2015–2017: Peach Panther and Aquaberry Aquarius === Riff Raff announced his intention to release his second studio album Peach Panther on June 1, 2015. The first single, "Spazz Out" featuring production from Travis Barker was released around this time, however the album itself would end up being delayed until 2016. He then released an EP entitled Trench Coat Towers in early November 2015. He extended the release date for Peach Panther several times, with early 2016 being cited on his Instagram as the current date. He was also featured on several singles during 2015, including "Doctor Pepper" with Diplo, CL, and OG Maco, and Flux Pavilion's single "Who Wants to Rock". In early 2016 he released the first single from Peach Panther, "Carlos Slim". The album was eventually released on June 24, 2016. In April 2016, Riff Raff announced a partnership with Stampede Management and BMG, raising US$4 million for his Neon Nation Corporation to invest in music as well as in "movies and talent across the globe to build an entertainment empire." Since his second studio album Peach Panther he has released 3 projects with DJ Afterthought starting out with 2016 Halloween mixtape, "BALLOWEEN" featuring Quavo, Skepta, Trae tha Truth, Travis Barker and many more. Most of the songs off "BALLOWEEN" have been stashed away for month's and were finally released. Next, January 30, 2017 Aquaberry Aquarius dropped having super stars Wiz Khalifa and Lisa Cimorelli from the 6 sister group Cimorelli, also having underground famous rap stars Bones, Fat Nick and Germ.
== Published works == A Method for Identifying the Photoproducts, Mechanisms, and Toxicity of Petroleum from the Deepwater Horizon by High-Performance Liquid Chromatography, DNPHi Derivatization, and Solar Simulation
She eventually succeeded in purifying components of the coat that were not clathrin and are now known as adaptor proteins. These proteins sit between clathrin, which forms the vesicle's outer shell and also the vesicle membrane. Continuing, Margaret discovered that there were two different populations of clathrin-coated vesicles, one that uses AP-2 at the plasma membrane and one that uses AP-1 and was associated with intracellular membranes. AP-1 and AP-2 are both heterotetramers with related subunits. They both have two large subunits and the other subunit is closely related in AP-1 and AP-2.
chirality A property of asymmetry in which a molecule or ion is distinguishable from its mirror image such that it cannot be superposed upon it by any combination of geometric rotations, translations, or some conformational changes. Such a molecule or ion is said to be chiral, and exists in two forms, known as enantiomers, which are stereoisomers of each other; these forms are distinguished as either "right-handed" or "left-handed" by their absolute configuration or some other criterion. Several different types of asymmetry can give rise to chirality, most commonly when molecules possess stereogenic elements such as one or more stereocenters (central chirality), a stereogenic axis (axial chirality), or a stereogenic plane (planar chirality); additionally, the inherent curvature of a molecule can cause it to possess inherent chirality.
Sources: en.wikipedia.org
For services to Child Road Safety. Kenneth Fitzpatrick. Lifeboat Operations Manager, Porthdinllaen Lifeboat Station, Royal National Lifeboat Institution. For services to Maritime Safety. Barry Flack. For services to the Jewish Community in the London Borough of Barnet. Margaret Elizabeth Flanagan. Member, Inner Wheel Club of Ballymena. For voluntary services to the community in Ballymena, County Antrim. John Campbell Forrester. President and Poppy Appeal Organiser, Driffield Branch, Royal British Legion. For voluntary service to Veterans in East Yorkshire. Claire Forsythe. Duke of Edinburgh's Award Officer, Probation Board for Northern Ireland. For services to the Rehabilitation of Offenders. Susan Joan Foster. For voluntary service in Hampshire. Richard Charles Fowler. Library Lead, Harbury Community Library, Warwickshire. For services to Libraries. Dr Jennifer Ann Frow. Volunteer, Bewdley Tennis Club. For services to Lawn Tennis in Worcestershire. Robert Francis Fyfe. Chair and Director, Runway Theatre Company. For services to the Arts and to the community in Glasgow. Melanie Jane Gardner. Fine and Decorative Arts Curator, Tullie House Museum, Carlisle. For services to Arts and Culture in Cumbria. Joseph William Garvey. For services to the community in County Armagh. Peter William Garwood. For services to the community in Barrow-in-Furness, Cumbria. Christine Frances Gatfield. Founder, Dove Cottage Day Hospice. For services to the Terminally Ill. Patricia Mary Gaywood. Membership Secretary, The Forty Club. For voluntary service to Cricket. Andrew Gell.
==== Using detrital zircon age abundance ==== In a global scale, detrital zircon age abundance can be used as a tool to infer significant tectonic events in the past. In Earth's history, the abundance of magmatic age peaks during periods of supercontinent assembly. This is because supercontinent provides a major crustal envelop selectively preserve the felsic magmatic rocks, resulting from partial melts. Thus, many detrital zircons originate from these igneous provence, resulting similar age peak records. For instance, the peak at about 0.6–0.7 Ga and 2.7 Ga (Figure 6) may correlate the break-up of Rodinia and supercontinent Kenorland respectively.
In early May 1990, one of the two A&M researchers, Kevin Wolf, acknowledged the possibility of spiking, but said that the most likely explanation was tritium contamination in the palladium electrodes or simply contamination due to sloppy work. In June 1990 an article in Science by science writer Gary Taubes destroyed the public credibility of the A&M tritium results when it accused its group leader John Bockris and one of his graduate students of spiking the cells with tritium. In October 1990 Wolf finally said that the results were explained by tritium contamination in the rods. An A&M cold fusion review panel found that the tritium evidence was not convincing and that, while they couldn't rule out spiking, contamination and measurements problems were more likely explanations, and Bockris never got support from his faculty to resume his research. On 30 June 1991, the National Cold Fusion Institute closed after it ran out of funds; it found no excess heat, and its reports of tritium production were met with indifference. On 1 January 1991, Pons left the University of Utah and went to Europe. In 1992, Pons and Fleischmann resumed research with Toyota's IMRA lab in France. Fleischmann left for England in 1995, and the contract with Pons was not renewed in 1998 after spending $40 million with no tangible results. The IMRA laboratory stopped cold fusion research in 1998 after spending £12 million. Pons has made no public declarations since, and only Fleischmann continued giving talks and publishing papers.
Like the human practice of veganism, vegan dog foods are those formulated with the exclusion of ingredients that contain or were processed with any part of an animal, or any animal byproduct. A 2023 systematic review found no evidence of serious impacts on animal health from vegetarian cat and dog diets; however, the authors noted that the studies suffered from issues such as selection bias, low sample size, and short feeding periods and recommended further research. The omnivorous domestic canine has evolved to metabolize carbohydrates and thrive on a diet lower in protein, and a vegan diet may be adequate if properly formulated and balanced. Popularity of this diet has grown with a corresponding increase in people practicing vegetarianism and veganism as well as with growing concerns about environmental issues such as climate change or awareness of the large environmental impacts of animal agriculture. Vegetarian dog foods are produced to either assuage a pet owner's ethical concerns or for animals with extreme allergies. Due to the exclusion of animal products and by-products, which are primary ingredients of conventional dog food, many nutrients that would otherwise be provided by animal products need to be provided by replacement, plant-based ingredients. While both animal and plant products offer a wide range of macro and micronutrients, strategic formulation of plant ingredients should be considered to meet nutritional requirements, as different nutrients are more abundant in different plant sources.
Sources: en.wikipedia.org
PT-141 is a laboratory code for bremelanotide, a synthetic peptide that activates melanocortin receptors. It has been developed both as an injectable pharmaceutical product and as a research chemical. The two contexts differ sharply in how identity, purity, and dosing are controlled.
It is neither a steroid nor a naturally occurring human hormone. Bremelanotide is a manufactured peptide that mimics part of the melanocortin signalling system by binding receptor proteins. Its effects come from receptor activation, not from replacing a circulating hormone.
The internal lactam bridge locks the peptide into a defined shape, which raises receptor affinity and slows enzymatic breakdown. Linear versions of the same sequence are less stable and bind more weakly. Ring geometry is therefore central to how the molecule behaves in the body.
Trial results generally show a small to moderate average improvement in desire scores relative to placebo. The distribution of responses is wide, and some participants show little measurable change. Group averages should not be read as a prediction for any single person.